Tata Consultancy Services’ Broad Portfolio, End-to-End R&D IT and Business Services Capabilities, Vast Geographic Footprint and Strong Experience, Cited as Key Strengths
NEW YORK | MUMBAI, October 04, 2021: Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been positioned as a Leader in the IDC MarketScape for Worldwide Life Science R&D BPO Services1 .
According to the report, “TCS’ broad portfolio; the company’s end-to-end R&D IT and business services capabilities, including strategic consulting and cloud-based, platform-based solutions; its vast geographic footprint; and its years of experience in the life science industry, all make TCS a formidable option for companies seeking a preferred vendor to address their R&D ITO needs.” It goes on to say that “TCS is focusing on an advisory-led transformation approach for higher digital adoption and value creation with a focus on IP-based digital health, real-world evidence, scientific collaboration, connected smart labs, data-driven development, digital clinical trials, automation, and regulatory intelligence.”
“We leverage our deep contextual knowledge of the life sciences R&D value chain, cutting-edge R&D IT capabilities, investments in innovation around genomics and drug development, and expertise in AI / cognitive computing to help customers accelerate and scale up R&D programs which are core to their growth and transformation journeys,” said Vikram Karakoti, Global Co-Head, Life Sciences, TCS. “This leadership position is a reflection of our strong vision, sustained investments in relevant capabilities, innovation efforts and the resultant market success.”
TCS partners with leading life sciences companies to drive innovation and reimagine their R&D processes by leveraging next generation platforms and emerging technologies. The company offers a full set of services spanning consulting, cognitive business operations and digital transformation services, as well as platform solutions in the life sciences sector.
TCS’ offerings span clinical project planning and budgeting, data anonymization, pharmacokinetic analysis and medical device support, content reuse in medical writing, development of e-consent related content forms, impact assessment for chemistry, manufacturing, and control (CMC), labeling and CMC authoring support, and development of digital content factory services for multi-channel marketing. Within pharmacovigilance, it has local safety officers who work with the respective qualified persons for pharmacovigilance to better support its customers.
At the core of its success as the preferred R&D partner for leading life sciences companies globally is TCS’ deep domain knowledge and intellectual property around drug development. Its flagship offering, TCS ADD, is a cloud-native, cognitive platform that reimagines the end-to-end drug development value chain using digital technologies to enhance patient and user experience and improve clinical trial outcomes. The platform leverages the TCS Decision Fabric™ AI engine and spans across data standardization to safety and regulatory compliance.
Additionally, TCS leverages it Co-innovation Network that includes academia, government institutions, start-ups and technology providers to help customers further accelerate their innovation.
About IDC Marketscape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.
About Tata Consultancy Services (TCS)
Tata Consultancy Services is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for over 50 years. TCS offers a consulting-led, cognitive powered, integrated portfolio of business, technology and engineering services and solutions. This is delivered through its unique Location Independent Agile™ delivery model, recognized as a benchmark of excellence in software development.
A part of the Tata group, India's largest multinational business group, TCS has over 500,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $22.2 billion in the fiscal year ended March 31, 2021 and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. TCS' proactive stance on climate change and award-winning work with communities across the world have earned it a place in leading sustainability indices such as the MSCI Global Sustainability Index and the FTSE4Good Emerging Index. For more information, visit www.tcs.com.
1 IDC MarketScape: Worldwide Life Science R&D BPO Services, 2021 Vendor Assessment, IDC #US48126821, August 2021
TCS media contacts:
Phone: +65 9139 3668
Australia and New Zealand
Phone: +61 422 989 682
Phone: +1 647 790 7602
Phone: +31 615 903387
Phone: +91 22 67789098
Phone: +91 22 6778 9999
Middle East & Africa
Phone: +81 80 2115 0989
Phone: +569 6170 9013
Phone: +44 20 3155 2421
Phone: +1 203 984 3978